Tissue distribution of the DEC-205 protein that is detected by the monoclonal antibody NLDC-145. I. Expression on dendritic cells and other subsets of mouse leukocytes - PubMed (original) (raw)
Tissue distribution of the DEC-205 protein that is detected by the monoclonal antibody NLDC-145. I. Expression on dendritic cells and other subsets of mouse leukocytes
K Inaba et al. Cell Immunol. 1995 Jun.
Abstract
Prior studies by a variety of groups demonstrated that the mAb NLDC-145 reacted primarily with dendritic cells (DCs) and the epithelial cells of the thymic cortex. We recently reported that this mAb recognizes DEC-205, a 205-kDa integral membrane glycoprotein with a unique amino-terminal sequence, and raised a rabbit polyclonal antibody to purified DEC-205 with higher affinity for the blotted antigen than the original mAb. Here we utilize both the polyclonal and NLDC-145 to reassess the expression and function of DEC-205 on leukocytes. By cytofluorography, DCs derived from the epidermis (Langerhans cells) and from proliferating bone marrow progenitors (BMDCs) expressed high levels (2-3 logs) of DEC-205, while freshly isolated spleen DCs comprised two subsets, most (80%) staining at low levels (< or = 1 log), the remainder moderately (1.5 logs). DEC-205 epitopes were sensitive to trypsin, but were regenerated in culture. Resident and inflammatory peritoneal macrophages did not express the antigen, except for small amounts on thioglycollate-elicited cells. B cells from spleen, lymph node, bone marrow, blood, and peritoneal fluid expressed levels of DEC-205 that were 10- to 50-fold lower than those on BMDCs. Marrow pro- and pre-B cells did not express DEC-205. Polyclonal anti-DEC-205 failed to inhibit either stimulation of a primary mixed leukocyte reaction by DCs in vitro, or a local graft vs host response in vivo, where parental T cells were injected into F1 mice. DEC-205 is therefore more broadly expressed on leukocytes than previously appreciated, but its function remains unclear.
Similar articles
- Tissue distribution of the DEC-205 protein that is detected by the monoclonal antibody NLDC-145. II. Expression in situ in lymphoid and nonlymphoid tissues.
Witmer-Pack MD, Swiggard WJ, Mirza A, Inaba K, Steinman RM. Witmer-Pack MD, et al. Cell Immunol. 1995 Jun;163(1):157-62. doi: 10.1006/cimm.1995.1110. Cell Immunol. 1995. PMID: 7758126 - Expression of human DEC-205 (CD205) multilectin receptor on leukocytes.
Kato M, McDonald KJ, Khan S, Ross IL, Vuckovic S, Chen K, Munster D, MacDonald KP, Hart DN. Kato M, et al. Int Immunol. 2006 Jun;18(6):857-69. doi: 10.1093/intimm/dxl022. Epub 2006 Mar 31. Int Immunol. 2006. PMID: 16581822 - Advancing immunomodulation by in vivo antigen delivery to DEC-205 and other cell surface molecules using recombinant chimeric antibodies.
Iberg CA, Hawiger D. Iberg CA, et al. Int Immunopharmacol. 2019 Aug;73:575-580. doi: 10.1016/j.intimp.2019.05.037. Epub 2019 Jun 19. Int Immunopharmacol. 2019. PMID: 31228685 Free PMC article. Review. - Applications of Antibody-Based Antigen Delivery Targeted to Dendritic Cells In Vivo.
Bourque J, Hawiger D. Bourque J, et al. Antibodies (Basel). 2022 Jan 25;11(1):8. doi: 10.3390/antib11010008. Antibodies (Basel). 2022. PMID: 35225867 Free PMC article. Review.
Cited by
- Intensified and protective CD4+ T cell immunity in mice with anti-dendritic cell HIV gag fusion antibody vaccine.
Trumpfheller C, Finke JS, López CB, Moran TM, Moltedo B, Soares H, Huang Y, Schlesinger SJ, Park CG, Nussenzweig MC, Granelli-Piperno A, Steinman RM. Trumpfheller C, et al. J Exp Med. 2006 Mar 20;203(3):607-17. doi: 10.1084/jem.20052005. Epub 2006 Feb 27. J Exp Med. 2006. PMID: 16505141 Free PMC article. - Route of antigen uptake differentially impacts presentation by dendritic cells and activated monocytes.
Kamphorst AO, Guermonprez P, Dudziak D, Nussenzweig MC. Kamphorst AO, et al. J Immunol. 2010 Sep 15;185(6):3426-35. doi: 10.4049/jimmunol.1001205. Epub 2010 Aug 20. J Immunol. 2010. PMID: 20729332 Free PMC article. - STxB as an Antigen Delivery Tool for Mucosal Vaccination.
Tartour E, Johannes L. Tartour E, et al. Toxins (Basel). 2022 Mar 10;14(3):202. doi: 10.3390/toxins14030202. Toxins (Basel). 2022. PMID: 35324699 Free PMC article. Review. - DCs-based therapies: potential strategies in severe SARS-CoV-2 infection.
Han J, Sun J, Zhang G, Chen H. Han J, et al. Int J Med Sci. 2021 Jan 1;18(2):406-418. doi: 10.7150/ijms.47706. eCollection 2021. Int J Med Sci. 2021. PMID: 33390810 Free PMC article. Review. - Cutting-Edge Delivery Systems and Adjuvants in Tolerogenic Vaccines: A Review.
Puricelli C, Boggio E, Gigliotti CL, Stoppa I, Sutti S, Rolla R, Dianzani U. Puricelli C, et al. Pharmaceutics. 2022 Aug 25;14(9):1782. doi: 10.3390/pharmaceutics14091782. Pharmaceutics. 2022. PMID: 36145531 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous